Baldwin Brothers LLC Sanofi Transaction History

Baldwin Brothers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	BUY	$49.36 - $54.25 $14,808 - $16,275	300 New	300 $16,000
Q4 2019 Jan 29, 2020	SELL	$44.25 - $50.86 $1,770 - $2,034	-40 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$40.34 - $46.64 $333,006 - $385,013	-8,255 Reduced 99.52%	40 $2,000
Q2 2019 Jul 19, 2019	SELL	$40.43 - $44.3 $84,741 - $92,852	-2,096 Reduced 20.17%	8,295 $359,000
Q3 2018 Oct 26, 2018	SELL	$40.0 - $44.84 $29,200 - $32,733	-730 Reduced 6.56%	10,391 $464,000
Q4 2017 Jan 24, 2018	BUY	$42.86 - $50.61 $246,102 - $290,602	5,742 Added 106.75%	11,121 $478,000
Q3 2017 Oct 26, 2017	BUY	$47.04 - $50.34 $253,028 - $270,778	5,379	5,379 $268,000

803

266M

1.82M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $147B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Brothers LLC with notifications on news.